Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

Market Cap	40.00M -8.9%
Revenue (ttm)	9.33M +83.0%
Net Income	-493.17K
EPS	-0.00
Shares Out	150.93M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,900
Open	0.2650
Previous Close	n/a
Day's Range	0.2600 - 0.2650
52-Week Range	0.1550 - 0.2900
Beta	-0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About KLSE:MGRC

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. Its flagship product, Dtect genetic screening tests which inspects DNA for markers associated with genetic variations that influence various biological processes. The company also offers genome sequencing services for humans, animals, plants, and microbes and other living organisms; transcriptome sequencing; and metagenomics and metatranscriptomics. In addition, it provides genome analy...

• Industry: Commercial Physical and Biological Research
• Founded: 2004
• Employees: 33
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: MGRC

Financial Performance

In 2025, KLSE:MGRC's revenue was 8.02 million, an increase of 45.29% compared to the previous year's 5.52 million. Losses were -2.38 million, -43.19% less than in 2024.